CINA CHEST vs DeepRhythmAI
AI Verdict
Choose CINA CHEST if…
Choose CINA CHEST if your emergency department or radiology practice requires immediate AI-powered triage and notification for life-threatening chest conditions. This tool is ideal for rapidly identifying suspected Pulmonary Embolism or Aortic Dissection on CT angiography scans, enabling faster intervention and improved patient outcomes in critical situations.
View CINA CHEST →Choose DeepRhythmAI if…
Choose DeepRhythmAI if your cardiology practice or health system needs to revolutionize cardiac arrhythmia detection and classification from ECG data. This cloud-based AI algorithm offers superior accuracy and efficiency in analyzing vast amounts of ECG data, streamlining clinical workflows and reducing missed diagnoses for a wide range of arrhythmias.
View DeepRhythmAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CINA CHEST | DeepRhythmAI |
|---|---|---|
| Pricing | Subscription-based | Contact vendor for pricing information |
| Deployment | CINA runs on the AVI Platform or a third-party platform, between your scanner and your PACS. Results simply appear as an additional series, with an alert when a finding is positive for one of the pathologies CINA detects. | Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepRhythmAIBoth tools aim to streamline clinical workflows and offer cloud-based access. DeepRhythmAI's 'device-agnostic' nature and claims of significant efficiency increases (up to 65%) suggest a highly adaptable and user-centric design for integrating with existing ECG devices and accelerating reporting. CINA CHEST's standalone web application and notification system are also beneficial, but DeepRhythmAI's broader integration and quantified efficiency gains give it a slight edge in overall usability.
Clinical Value
DeepRhythmAIBoth are FDA-cleared and address critical cardiac conditions. DeepRhythmAI provides quantifiable metrics for reducing missed diagnoses (14x to 114x fewer) and increasing efficiency (up to 65%), which are strong indicators of significant clinical impact and superior accuracy in its domain. While CINA CHEST offers rapid triage for acute, life-threatening conditions, DeepRhythmAI's specific, high-impact clinical outcome metrics are more compelling.
Pricing & Value
CINA CHESTBoth tools lack transparent pricing details, requiring direct contact for specifics. However, CINA CHEST explicitly states a 'subscription-based' model, which offers a clearer, more predictable pricing structure than the generic 'enterprise' designation with unknown details from DeepRhythmAI. This slight clarity in pricing model gives Tool A an edge in transparency.
Enterprise Readiness
CINA CHESTCINA CHEST offers superior deployment flexibility with cloud-based, on-premise (dedicated hardware), and virtualized (VM, Docker) options, which is crucial for integrating into diverse enterprise IT environments. While DeepRhythmAI has a longer history, a global customer base, and an API, its cloud-only deployment is less adaptable for all enterprise needs compared to Tool A's comprehensive options.
Innovation
DeepRhythmAIDeepRhythmAI explicitly highlights the use of advanced 'CNN and Transformer models' and an exceptionally large training dataset of '250 billion+ annotated heartbeats.' This indicates a higher degree of technical innovation in its AI architecture and scale of data utilization compared to CINA CHEST's general mention of deep learning algorithms.
Support & Docs
TieNeither the provided structured facts nor a general web search yielded specific information regarding the availability or quality of support and documentation for either tool. Therefore, it is not possible to distinguish between them on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CINA CHEST | DeepRhythmAI |
|---|---|---|
| Name | CINA CHEST | DeepRhythmAI |
| Company | Avicenna.AI | Medicalgorithmics S.A. |
| Primary Function/Focus | AI-powered radiological triage and notification for Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. | AI algorithm for cardiac arrhythmia detection and classification from ECG data. |
| Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology |
| Key Detections/Analysis | Detection of Pulmonary Embolism (PE) on Chest CT angiography; Detection of Aortic Dissection (AD) on Chest or Thoraco-abdominal CT angiography; Flags and communicates suspected positive findings. | AI-powered arrhythmia detection and classification. |
| AI Technology Details | Utilizes artificial intelligence (deep learning algorithms). | Utilizes CNN and Transformer models; Trained on 250 billion+ annotated heartbeats. |
Videos
Demos, reviews, and walkthroughs featuring CINA CHEST and DeepRhythmAI.